Arkansas Department of Health releases measles vaccine data
LITTLE ROCK, Ark. – Officials with the Arkansas Department of Health released recent data on the measles vaccine rate in the state, showing high percentages across certain age groups.
According to data from the ADH, the percentages range from 82% to 92% in children born in 2021 to kindergarteners during the 2023-2024 school year.
Children born in 2021 by age 24 months – 82.40%
Children born in 2021 by age 35 months – 86.90%
Kindergartens for the 2023-24 school year – 92.50%
Children ages 13-17 for the 2023 calendar year – 91.60%
The data comes after Arkansas health officials confirmed the fourth measles case in the state in 2025, marking the first case of community spread of measles in Arkansas this year.
Unvaccinated child contracts first Arkansas measles case since 2018
The first case since 2018 was reported earlier this month, and the remaining three were reported within the last two weeks.
Cases have been reported in Saline County and Faulkner County. Health officials reported that all the confirmed cases were children who were unvaccinated.
According to ADH officials, those who received the MMR vaccine or were born before 1957 are generally considered immune.
Measles: What are the first symptoms to look for?
To learn more about measles, visit Healthy.Arkansas.gov.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Oakland County issues alert for measles exposure site in Rochester Hills
FOX 2 - The Oakland County Health Division is notifying the public about a Rochester Hills measles exposure site involving a person from another county. The exposure site is a medical office building at 3950 S. Rochester Road at the corner of South Boulevard on Tuesday, June 3, according to a release from the Oakland County Health Division. Anyone there between 8 a.m. and 7:30 p.m. may have been exposed to measles. If you think you were exposed to measles at this location on June 3, Immune Globulin (IG) treatment is effective within six days of exposure for high-risk individuals. Those considered high-risk include women who are pregnant, unvaccinated children under age 5 and those who have a weakened immune system due to illness and disease including diabetes or HIV, malnutrition and/or medications. If you are not eligible for IG, monitor symptoms through June 24. If symptoms develop, call ahead to your health care provider. Individuals born in or before 1957 are considered immune. Measles is a highly contagious, vaccine-preventable disease that is spread by direct person-to-person contact and through the air. The Health Division recommends unvaccinated individuals ages 1 year and older receive a measles vaccination to protect themselves and those around them. Anyone who doesn't have a record of two MMR vaccines, unsure if they've have been vaccinated, or unsure if you've had measles in the past, needs to contact their health care provider. Measles can live for up to two hours in the air where an infected person coughed or sneezed. Symptoms of measles usually begin 7-14 days after exposure, but can appear up to 21 days after exposure, and may include: High fever (may spike to over 104°F Cough Runny nose Red, watery eyes (conjunctivitis) Tiny white spots on the inner cheeks, gums and roof of mouth (Koplik Spots) 2-3 days after symptoms begin. A rash that is red, raised, blotchy; usually starts on face, spreads to trunk, arms and legs 3-5 days after symptoms begin. The MMR vaccine is available through some health care providers, Oakland County Health Division offices in Southfield and Pontiac, and many pharmacies. Health Division offices are located at the following addresses: North Oakland Health Center, 1200 N. Telegraph Road, Building 34 East, Pontiac South Oakland Health Center, 27725 Greenfield Road, Southfield. Health Division clinics hours are Monday, Wednesday and Friday 8:30 a.m. – 5 p.m. Tuesday 9:30 a.m. – 6 p.m. and Thursday 7:30 a.m. – 5 p.m. Visit for more information on measles, or contact Nurse on Call, 8:30 a.m. to 5 p.m. Monday through Friday, at 800-848-5533 or noc@
Yahoo
3 hours ago
- Yahoo
Myths VS Facts: What health officials want you to know about the MMR vaccine
SALT LAKE CITY () — With measles cases increasing in the U.S., including two recent brushes with the disease in Utah, health officials want to remind the public that the safest protection against it is the measles, mumps, and rubella (MMR) vaccine. Earlier this week, the Utah Department of Health and Human Services announced they are monitoring a potential measles exposure in southwestern Utah after an unvaccinated individual from out of state visited the area while infectious with the disease. Health officials monitoring potential measles exposure in southwestern Utah Additionally, health officials said a through the Salt Lake City International Airport in May. This incident was determined to be low risk, as the passenger was vaccinated. Although there are no recorded cases in Utah yet, with some in neighboring states, health officials want residents to know that there could be some soon and to be prepared. 'It is the time to go and check what your vaccine status is, what your kid's vaccine status is, and make sure everybody has the right vaccine, so you don't have to worry about this. There's a great way to prevent it, you can take it, it's a good safe, effective way to not have measles get into your family,' said Dr. Leisha Nolen, the state epidemiologist. Health officials report that measles is one of the most contagious diseases. Measles signs and symptoms generally appear about 10-14 days after exposure, with common symptoms including high fever, cough, runny nose, sore throat, and white spots in the mouth known as Koplik's spots. In addition, a rash with small red spots may appear after 3-5 days. The CDC reports that measles was declared eliminated from the United States in 2000, which is described as an absence of the continuous spread of disease for more than 12 months. But, there have been more cases in recent years. Currently the CDC says there are 1,168 confirmed measles cases in the United States. There have been three confirmed deaths from measles in the U.S. in 2025. Passenger with measles travels through SLC airport, determined low risk for spread met with Dr. Andrew Pavia, professor of pediatric infectious diseases and chief of hospital epidemiology at Primary Children's Hospital, to learn more about the vaccine and its effectiveness, as well as break down some myths. 'We've seen an unprecedented amount of measles in the country this year, so we've just been waiting for it to arrive in Utah, ' he said. '…We've been preparing for it. Now, with this exposure in Saint George, it's likely that there will be more cases. Many people have never seen measles, even their parents may not have seen it. It's a pretty bad disease — and when we say childhood illness, we think of something like chickenpox, where kids are uncomfortable for two or three days, and that's it. Measles is miserable in its average form, but can be dangerous, or even deadly. That's why we really care about it, and that's why we really, really want everyone to help protect their children.' The Centers for Disease Control and Prevention said that the MMR vaccine is safe and effective, and that it protects you from measles, mumps, rubella, and other serious diseases. According to the CDC, almost everyone who has not had the MMR vaccine will get sick if they are exposed to those viruses. The says that numerous studies have been conducted over the year, confirming its safety and efficacy. Minimal risks, such as swelling in cheeks or neck and allergic reactions can occur, the AAP said, but the protecton it provides far outweighs the risks and more serious outcomes that can come from measles itself. Dr. Pavia said that the vaccine has low rates of potential side effects and protects you against measles for life. 'This vaccine has been extremely carefully studied. It has been studied in placebo-controlled trials, and every time it's been tweaked or improved slightly, the new version has been compared to the old one,' Dr. Pavia said. 'It's very, very safe by the standards of any medicine you want to look at. That's not to say there aren't some side effects. Kids, not uncommonly, can get a fever after the MMR vaccine. They can also get a rash 1 to 2 weeks out, or some joint aches. It's a little bit more common in adults who get it, but serious complications of this vaccine are extraordinarily rare and rarer than with most other vaccines.' One dose of the MMR vaccine is 93% effective against measles, while two doses are 97% effective, according to the CDC. The CDC says that although some vaccinated people may still get measles, mumps, or rubella if exposed to the viruses, their symptoms will generally be milder, and they will be less likely to spread the disease. The CDC said that the MMR vaccine has been thoroughly studied in the United States and other countries and no link between autism and the MMR vaccine has been found. Although the vaccine, like medicine, can have side effects, these are typically mild and go away on their own. 'There are no long-term consequences of the MMR vaccine and it's been incredibly well-studied because of the concerns people have raised,' Dr Pavia. said. 'There are over 20 studies looking at whether or not there's any connection to autism. That's a common thing that's brought up, and these studies done in many different countries have showed absolutely no link. With a serious disease and a very good vaccine, if you're going to pick one vaccine to get this summer, it should be the one.' Some may believe getting measles and developing natural immunity is safer than getting the vaccine, however, say otherwise, as natural infection comes with more risks. Dr. Pavia explained getting the disease from natural infection is more dangerous with serious cases leading to the hospital, death, or brain damage. 'If none of those things happen, you're going to be miserable, or your child's going to be miserable for four to eight days,' Dr. Pavia said. '… If I had a good vaccine to offer for rattlesnake bites, would you say it's better to get bitten by a rattlesnake and develop some immunity to the venom or to get a vaccine?' Both recent brushes with measles in Utah were related to travel, which we will be seeing more of this summer. Dr. Pavia said now is a good time to think about getting your kids vaccinated and protected. 'Utahns are going to be traveling with their kids this summer, going to places where there's even more measles. Of course, Utah's an important destination for people during the summer, so we can expect more importations, more people showing up in Utah with measles. It's really important that we and our kids have the best protection possible,' he said. Dr. Pavia also emphasized the importance of seeking out reputable resources to learn more and educate yourself on MMR vaccine information, such as speaking to your own family practitioner. 'I think it's really important for people to educate themselves. We say that a lot, but then you go to social media or talk to friends, and there's just so much misinformation out there. Educate yourself, but look for reliable sources. Go to the Utah State Department of Health. Look at the University of Utah or Intermountain websites. Go to Medscape. There are lots of good sources of information where you can learn more, but just be careful in what you consume,' he said. '…I hope you and your kids have a great summer, but please be safe and be healthy out there.' Musk floats 'The American Party' after Trump tiff Myths VS Facts: What health officials want you to know about the MMR vaccine Good4Utah Road Tour: Willard Bay State Park Lori Vallow Daybell back in court, charged with conspiracy to murder ex nephew-in-law Man charged with assault for allegedly attacking and strangling neighbor Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
4 hours ago
- Yahoo
H.C. Wainwright Initiates Coverage of Akebia Therapeutics (AKBA) With Buy Rating
Matthew Caufield, an analyst from H.C. Wainwright, initiated coverage of Akebia Therapeutics, Inc. (NASDAQ:AKBA) with a Buy rating and a $8 price target, on June 4. The analyst gave the optimistic rating due to the company's VAFSEO product and its potential in the CKD anemia market. VAFSEO is an approved treatment for anemia in adults with chronic kidney disease on dialysis. According to the analyst, the treatment is gaining considerable momentum among dialysis organizations, and this trend is anticipated to support near-term growth. He expects VAFSEO's ongoing launch to offset the effect of generics on AURYXIA, another product by Akebia Therapeutics, Inc. (NASDAQ:AKBA) that deals with hyperphosphatemia. A biopharmaceutical team in a laboratory analyzing new compounds to develop therapeutics. The analyst also reasoned that Akebia Therapeutics, Inc. (NASDAQ:AKBA) is positioned for success as it has secured contracts that cover almost all dialysis patients in the US. VAFSEO offers flexibility in its dosing regimen, ranging from 150mg to 600mg, making it a factor that allows for personalized treatment and potentially growing prescriptions. Caufield pointed out VAFSEO's oral administration as another reason supporting the optimistic rating, giving it an advantage over existing therapies, such as iron supplementation and erythropoiesis-stimulating agents. Akebia Therapeutics, Inc. (NASDAQ:AKBA) is a biopharmaceutical company that develops and commercializes drugs to treat metabolic and renal diseases. While we acknowledge the potential of AKBA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Sign in to access your portfolio
